Exchange: NASDAQ·Updated 07:54 PM EDT
PGNY logo

PGNYProgyny Inc

$31.37
$0.61
(1.98%)
Today
Closed $31.37
$0.00
(0.00%)
After Hours
EarningsAug 6
Mkt Cap$2.41B
Vol1.09M
News
all
press releases
Teladoc (TDOC) Reports Q2 Loss, Lags Revenue Estimates
Teladoc (TDOC) delivered earnings and revenue surprises of +12.50% and -1.26%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
More News
Labcorp Holdings Inc. (LH) Hit a 52 Week High, Can the Run Continue?
Labcorp (LH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks
Community Health Q2 Loss Wider Than Expected, 2026 View Lowered
CYH posts a wider-than-expected Q2 loss as revenues fall and the company cuts its 2026 revenue, EBITDA and earnings outlook.
Zacks
Danaher Q2 Earnings Beat Estimates, Life Sciences Sales Up Y/Y
DHR beats Q2 estimates as Life Sciences posts its strongest quarter in years, prompting the company to raise its 2026 adjusted EPS outlook.
Zacks
Progyny COO Cummings Sells 3,437 Shares for $109,000 -- Here's What That Means for Investors
Key PointsMelissa B. Cummings disposed of 3,437 shares for a total value of ~$109,000 on July 14, 2026...
Nasdaq News: Markets
5 Top Stocks With Relative Price Strength to Buy Right Now
JBHT, PGNY, BSET, VSXY and PARR stand out for relative price strength, positive estimate revisions and solid fundamentals amid market uncertainty.
Zacks
UnitedHealth Tops Q2 Earnings on Cost Control, Raises '26 Outlook
UNH beats Q2 earnings estimates on lower medical costs and stronger Optum Insight, then raises its 2026 EPS and cash flow outlook.
Zacks
Top 3 Health Care Stocks That May Implode This Month
Warning: RSI is above 70 for 3 overbought stocks in healthcare. Progyny, 10X Genomics, and Privia Health have high RSI values and strong price action.read more...
Benzinga
Progyny, Inc. (PGNY) Hit a 52 Week High, Can the Run Continue?
Progyny (PGNY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks
Why Progyny (PGNY) Might be Well Poised for a Surge
Progyny (PGNY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Zacks
<
1
2
>

Advertisement|Remove ads.